Avadel Pharma Announces FDA Authorization to Import Tentatively-Approved LUMRYZ Ahead of Anticipated Final Approval Decision By Investing.com Finances March 22, 2023 [ad_1] Avadel Pharma (AVDL) Proclaims FDA Authorization to Import Tentatively-Permitted LUMRYZ Forward of Anticipated Remaining Approval Resolution Avadel Prescribed drugs…
